A Decentralized Home-Based Study To Investigate Novel Objective Biomarker Of Gluten-Mediated Symptoms In Celiac Disease Participants (CeDar ROSE Study)
Clinical trial NCT05686369 · COMPLETED
Trial details
- NCT number
- NCT05686369
- Sponsor
- Chugai Pharmaceutical
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2023-03-08
- Primary completion
- 2023-10-05
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.